Supriya Lifescience appoints Rajeev Kumar Jain as CEO

He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business

SRL Diagnostics launches ‘Heart Assure Test’ to predict risk of cardiac event

Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup

South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData

There is also a growing interest in whole generation sequencing (WGS)

Pfizer and BioNTech submit application to USFDA for emergency use authorization of Omicron BA.4/BA.5-adapted bivalent vaccine booster for 5-11 year age

The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses

CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy

Unichem Laboratories sale its stake in Optimus Drugs

The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.

Bausch and Glenmark announce approval of RYALTRIS in Canada

RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray

19 crore AB-PMJAY cards created; 3.8 crore beneficiaries avails free benefit

AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds

Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals

The startup plans to provide free technology to dental clinics upon registration.

Lynparza approved in China as first-line maintenance treatment with Bevacizumab for HRD- positive advanced ovarian cancer

One in two women with advanced ovarian cancer has an HRD-positive tumor